Tuesday
Diabetes news
-Mineral may increase diabetes risk
The surprise discovery was made in a follow-up to animal studies indicating that the trace mineral helped the body handle glucose. Instead scientists in the US found that taking selenium supplements for a number of years increased the chances of developing diabetes.
"However, our understanding of the mechanisms whereby selenium would increase risk of diabetes is very limited at this time and this issue needs to be further explored. Nevertheless, I would not advise patients to take selenium supplements greater than those in multiple vitamins."
- Diabetes – Pumpkin Extract showed some promise for Insulin Reduction or Replacement
Researchers from East China Normal University discovered that diabetic rats fed pumpkin extract improved plasma insulin and insulin-positive (beta) cells to almost normal levels.
“Pumpkin extract is potentially a very good product for pre-diabetic persons, as well as those who have already developed diabetes,” said lead researcher, Tao Xia, from the East China Normal University.
The key ingredients it thought to be antioxidants and D-chiroinositol which helps mediates insulin activity. By improving the insulin levels, blood sugar levels were lowered. This in turn reduces the amount of oxidative oxygen species that further damage beta-cell membranes. This prevents further damage, which allows for some regeneration. The rats never did recoup full beta-cell capabilities because they were damaged beyond repair.
At this time studies have only been conducted on rats, and it would be too soon to say if humans would experience the same benefits.
-Researchers at American Diabetes Association 67th Scientific Sessions (ADA) has claimed that the use of an insulin pen device could considerably reduce the incidences of hypoglycaemia
The researchers have found that weak adherence to treatment for diabetes is highly correlated with enhanced risk for hospitalization and related expenses, with claims-related hypoglycaemia rates notably high for patients who are on conventional insulin. The study was conducted on 486 patients who were diagnosed with type2 diabetes and had been treated earlier with human or else analogue insulin administer by vial or syringe
The surprise discovery was made in a follow-up to animal studies indicating that the trace mineral helped the body handle glucose. Instead scientists in the US found that taking selenium supplements for a number of years increased the chances of developing diabetes.
"However, our understanding of the mechanisms whereby selenium would increase risk of diabetes is very limited at this time and this issue needs to be further explored. Nevertheless, I would not advise patients to take selenium supplements greater than those in multiple vitamins."
- Diabetes – Pumpkin Extract showed some promise for Insulin Reduction or Replacement
Researchers from East China Normal University discovered that diabetic rats fed pumpkin extract improved plasma insulin and insulin-positive (beta) cells to almost normal levels.
“Pumpkin extract is potentially a very good product for pre-diabetic persons, as well as those who have already developed diabetes,” said lead researcher, Tao Xia, from the East China Normal University.
The key ingredients it thought to be antioxidants and D-chiroinositol which helps mediates insulin activity. By improving the insulin levels, blood sugar levels were lowered. This in turn reduces the amount of oxidative oxygen species that further damage beta-cell membranes. This prevents further damage, which allows for some regeneration. The rats never did recoup full beta-cell capabilities because they were damaged beyond repair.
At this time studies have only been conducted on rats, and it would be too soon to say if humans would experience the same benefits.
-Researchers at American Diabetes Association 67th Scientific Sessions (ADA) has claimed that the use of an insulin pen device could considerably reduce the incidences of hypoglycaemia
The researchers have found that weak adherence to treatment for diabetes is highly correlated with enhanced risk for hospitalization and related expenses, with claims-related hypoglycaemia rates notably high for patients who are on conventional insulin. The study was conducted on 486 patients who were diagnosed with type2 diabetes and had been treated earlier with human or else analogue insulin administer by vial or syringe
Labels: diabetes, diabetes risk, insulin reduction
